Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Sang-Woong HanJoo Hark YiKyung Pyo KangHa Yeon KimYong-Soo KimHoon Young ChoiSung Kyu HaGheun-Ho KimYang Wook KimKyung-Hwan JeongSug Kyun ShinHo Jung KimPublished in: Journal of Korean medical science (2018)
TLV is effective in correcting hyponatremia and well-tolerated in Korean patients with SIADH. However, those with low body weight, low BMI or severe hyponatremia, could be vulnerable to overcorrection with the initial dose of 15 mg TLV.